| EMERGENT BIOSOLUTIONS |
| USA |
| Gesundheit |
| US29089Q1058 / A0LC2W |
| ER4 (Frankfurt) / EBS (NYSE) |
| FRA:ER4, ETR:ER4, ER4:GR, NYSE:EBS |
| - |
| https://www.emergentbioso.. |
|
Emergent BioSolutions Inc. is a life sciences company focused on preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats. Its current business centers on medical countermeasures and specialty prod..
>Volltext.. |
| 288.34 Mio. EUR |
| 679.4 Mio. EUR |
| 684.26 Mio. EUR |
| 206.82 Mio. EUR |
| -157.07 Mio. EUR |
| -3.06 EUR |
| 522.57 Mio. EUR |
| 125.18 Mio. EUR |
| 86.8 Mio. EUR |
| 1.15 |
| -6.71% |
| -230.73% |
| - |
| - |
| - |
| EMERGENT BIOSOLUTIONS, EMERGENT BIO |
| 06.10.26 |
|
||||
|
||||
|
||||
|